Paper Details

  1. Home
  2. Paper Details

Effects of amiodarone, amioder, and dronedarone on Trichomonas vaginalis.

Author: BenaimGustavo, BenchimolMarlene, de SouzaTatiana Guinancio, de SouzaWanderley

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Trichomoniasis is a common sexually transmitted infection caused by the parasite Trichomonas vaginalis. This study looked at the effects of three drugs, amiodarone, amioder, and dronedarone, on the growth and survival of T. vaginalis.
Paper Details　
Original Abstract of the Article :
Trichomonas vaginalis is a protozoan that causes human trichomoniasis, the most common non-viral sexually transmitted infection (STI) affecting approximately 278 million people worldwide. The current treatment for trichomoniasis is based on 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole, known as metr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00436-022-07521-8

データ提供：米国国立医学図書館（NLM）

Exploring New Horizons in Trichomoniasis Treatment

The realm of infectious disease is a vast and ever-changing desert, where the search for new treatments for trichomoniasis continues. This research investigates the potential of amiodarone and related compounds as alternative treatments for this common sexually transmitted infection. The study explores their impact on the growth and survival of Trichomonas vaginalis, seeking to identify new avenues for combating this prevalent disease.

A New Oasis in the Desert of Trichomoniasis Treatment

The study reveals that amiodarone and related compounds, particularly amioder and dronedarone, exhibit anti-parasite activity against Trichomonas vaginalis. This finding offers a glimmer of hope in the desert of trichomoniasis treatment, suggesting that these compounds could potentially provide new therapeutic options for managing this prevalent infection.

Navigating the Sands of Safety and Efficacy

The study emphasizes the importance of further research to fully understand the safety and efficacy of these compounds for treating trichomoniasis in humans. Careful evaluation is needed to determine their potential benefits and risks, ensuring that any new treatment strategies are safe and effective.

Dr.Camel's Conclusion

This research serves as a valuable guidepost in the desert of trichomoniasis treatment, highlighting the potential of amiodarone and related compounds as promising alternatives to existing therapies. As we continue to explore new horizons in infectious disease treatment, this research reminds us to remain open to innovative approaches and dedicated to finding safe and effective solutions for the challenges we face.

Date :
  1. Date Completed 2022-05-17
  2. Date Revised 2022-05-17
Further Info :

Pubmed ID

35435511

DOI: Digital Object Identifier

10.1007/s00436-022-07521-8

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.